SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 541 filers reported holding SEAGEN INC in Q2 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $50,067 | +32.7% | 236 | +20.4% | 0.01% | +50.0% |
| Q2 2023 | $37,722 | -4.9% | 196 | 0.0% | 0.00% | -20.0% |
| Q1 2023 | $39,684 | +183.3% | 196 | +79.8% | 0.01% | +150.0% |
| Q4 2022 | $14,008 | +100.1% | 109 | +101.9% | 0.00% | +100.0% |
| Q3 2022 | $7,000 | -41.7% | 54 | -16.9% | 0.00% | -50.0% |
| Q2 2022 | $12,000 | +140.0% | 65 | +97.0% | 0.00% | +100.0% |
| Q1 2022 | $5,000 | 0.0% | 33 | -2.9% | 0.00% | 0.0% |
| Q4 2021 | $5,000 | 0.0% | 34 | +21.4% | 0.00% | 0.0% |
| Q3 2021 | $5,000 | -16.7% | 28 | -24.3% | 0.00% | 0.0% |
| Q2 2021 | $6,000 | -73.9% | 37 | -78.1% | 0.00% | -80.0% |
| Q1 2021 | $23,000 | +155.6% | 169 | +225.0% | 0.01% | +150.0% |
| Q4 2020 | $9,000 | +12.5% | 52 | +33.3% | 0.00% | 0.0% |
| Q3 2020 | $8,000 | – | 39 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $6,419,005,000 | 42.04% |
| Ally Bridge Group (NY) LLC | 92,506 | $12,658,000 | 8.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 166,200 | $22,739,000 | 7.29% |
| Eagle Health Investments LP | 174,902 | $23,932,000 | 5.49% |
| Avoro Capital Advisors LLC | 1,865,000 | $255,188,000 | 4.71% |
| Lagoda Investment Management, L.P. | 47,955 | $6,562,000 | 4.67% |
| Nan Fung Group Holdings Ltd | 47,096 | $6,444,000 | 4.11% |
| Ikarian Capital, LLC | 150,000 | $20,525,000 | 4.09% |
| Antara Capital LP | 946,100 | $129,455,000 | 3.42% |
| SECTOR GAMMA AS | 84,730 | $11,594,000 | 2.99% |